159306-42-0 Usage
Class
Piperazine
Structure
Contains a substituted phenyl group
Type
Synthetic compound
Pharmacological Properties
Studied for potential properties
Receptors
Shows affinity for certain receptors in the central nervous system
Potential Drug Target
Investigated for conditions such as schizophrenia and depression
Synthesis
Used as a building block in the synthesis of various biologically active compounds
Research Status
Further research and clinical studies are required to understand potential therapeutic applications and safety profile.
Check Digit Verification of cas no
The CAS Registry Mumber 159306-42-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,9,3,0 and 6 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 159306-42:
(8*1)+(7*5)+(6*9)+(5*3)+(4*0)+(3*6)+(2*4)+(1*2)=140
140 % 10 = 0
So 159306-42-0 is a valid CAS Registry Number.
159306-42-0Relevant articles and documents
QUINOXALINE DERIVATIVES AS INHIBITORS OF THE TYROSINE KINASE ACTIVITY OF JANUS KINASES
-
Page/Page column 69-70, (2009/01/24)
The present invention relates to quinoxaline compound of the formula (I): wherein R1 is carbocyclyl or heterocyclyl, either of which is optionally substituted with 1, 2, 3, 4 or 5 R7; R2 is carbocyclyl or heterocyclyl, either of which is optionally substituted with 1, 2, 3, 4 or 5 R8; R3, R4, R5 and R6 are each independently hydrogen or R9; and R7, R8 and R9 are each independently selected from organic and inorganic substituents, their use in therapy of diseases, in particular diseases mediated by the tyrosine kinase activity of Janus kinases, including JAK-2 and JAK-3 kinases
